ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
81,985
-0,17%
Bitcoin
66 273,06
-0,55%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cellect Biotechnology Ltd (APOP)

  7. Cellect Biotechnology Ltd (APOP) Actualités

APOP

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:APOP
DateHeureSourceTitreSymboleSociété
28/06/202321h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/06/202321h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202321h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
20/03/202311h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
15/03/202319h40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
03/03/202322h20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
23/02/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202320h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
09/02/202312h05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/02/202312h03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202217h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
31/08/202213h28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APOPCellect Biotechnology Ltd
04/08/202217h45Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/08/202212h04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:APOPCellect Biotechnology Ltd
30/06/202222h58Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APOPCellect Biotechnology Ltd
14/06/202223h16Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:APOPCellect Biotechnology Ltd
14/04/202212h08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:APOPCellect Biotechnology Ltd
15/10/202122h01GlobeNewswire Inc.Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
27/09/202115h10GlobeNewswire Inc.Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
02/09/202122h20GlobeNewswire Inc.Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.NASDAQ:APOPCellect Biotechnology Ltd
24/08/202122h16GlobeNewswire Inc.Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
13/08/202122h20GlobeNewswire Inc.The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
03/08/202122h29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:APOPCellect Biotechnology Ltd
17/06/202100h58GlobeNewswire Inc.Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmace...NASDAQ:APOPCellect Biotechnology Ltd
19/04/202114h00GlobeNewswire Inc.Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical TrialNASDAQ:APOPCellect Biotechnology Ltd
29/03/202115h29GlobeNewswire Inc.Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
24/03/202122h26GlobeNewswire Inc.Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic MergerNASDAQ:APOPCellect Biotechnology Ltd
11/02/202117h52Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:APOPCellect Biotechnology Ltd
20/11/202014h00GlobeNewswire Inc.Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelera...NASDAQ:APOPCellect Biotechnology Ltd
 Showing the most relevant articles for your search:NASDAQ:APOP

Dernières Valeurs Consultées

LSE
KP2
Kore Potash
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés